Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Market Analysis & Valuation

UpdatedFeb 20, 2026
DataAggregated Company Financials
Companies372
  • 7D0.3%
  • 3M15.6%
  • 1Y31.5%
  • YTD15.2%

Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 4.1% in that time. Meanwhile, the market is actually up 32% over the past year. Looking forward, earnings are forecast to grow by 14% annually.

Trending IndustriesOil and GasRenewable Energy

Market Valuation and Performance

Has the Brazilian Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 20 Feb 2026R$5.5tR$3.9tR$394.1b10.6x13.9x1.4x
Sun, 18 Jan 2026R$4.9tR$4.2tR$398.7b9.4x12.3x1.2x
Tue, 16 Dec 2025R$4.8tR$4.2tR$401.6b9.8x12.1x1.2x
Thu, 13 Nov 2025R$4.8tR$5.5tR$571.7b9.6x8.5x0.9x
Sat, 11 Oct 2025R$4.3tR$4.2tR$434.7b8.6x10x1x
Mon, 08 Sep 2025R$4.5tR$4.2tR$436.4b8.9x10.3x1.1x
Wed, 06 Aug 2025R$4.2tR$4.2tR$406.8b8.9x10.4x1x
Fri, 04 Jul 2025R$4.5tR$4.2tR$406.1b9.5x11x1.1x
Sun, 01 Jun 2025R$4.5tR$4.8tR$418.5b9.4x10.8x1x
Tue, 29 Apr 2025R$4.5tR$4.7tR$404.0b8.9x11.1x1x
Thu, 27 Mar 2025R$4.4tR$4.7tR$411.1b8.4x10.6x0.9x
Sat, 22 Feb 2025R$4.3tR$4.6tR$473.4b8.3x9x0.9x
Mon, 20 Jan 2025R$4.1tR$4.6tR$481.0b8.2x8.6x0.9x
Wed, 18 Dec 2024R$4.2tR$4.6tR$481.2b8.5x8.8x0.9x
Fri, 15 Nov 2024R$4.4tR$4.5tR$456.4b9.1x9.6x1x
Sun, 13 Oct 2024R$4.5tR$4.4tR$428.9b9.5x10.5x1x
Tue, 10 Sep 2024R$4.7tR$4.4tR$427.0b10.2x10.9x1.1x
Thu, 08 Aug 2024R$4.5tR$4.4tR$457.0b9.7x9.7x1x
Sat, 06 Jul 2024R$4.4tR$4.3tR$446.5b10x9.8x1x
Mon, 03 Jun 2024R$4.3tR$4.3tR$445.1b10x9.6x1x
Wed, 01 May 2024R$4.5tR$4.3tR$457.8b10.1x9.8x1x
Fri, 29 Mar 2024R$4.6tR$4.3tR$457.0b10.4x10x1.1x
Sun, 25 Feb 2024R$4.6tR$4.4tR$465.4b10.3x9.9x1.1x
Tue, 23 Jan 2024R$4.5tR$4.3tR$466.8b11.5x9.7x1x
Thu, 21 Dec 2023R$4.7tR$4.4tR$467.5b11.7x10.1x1.1x
Sat, 18 Nov 2023R$4.5tR$4.4tR$471.3b10.4x9.5x1x
Mon, 16 Oct 2023R$4.2tR$4.5tR$504.1b10.6x8.3x0.9x
Wed, 13 Sep 2023R$4.3tR$4.5tR$506.1b11.4x8.5x1x
Fri, 11 Aug 2023R$4.4tR$4.5tR$511.4b12.2x8.6x1x
Sun, 09 Jul 2023R$4.4tR$4.6tR$552.8b11.9x8x1x
Tue, 06 Jun 2023R$4.2tR$4.6tR$554.3b11.4x7.6x0.9x
Thu, 04 May 2023R$3.9tR$4.6tR$575.6b9.7x6.7x0.8x
Sat, 01 Apr 2023R$3.9tR$4.6tR$595.3b9.9x6.5x0.8x
Mon, 27 Feb 2023R$4.0tR$4.6tR$608.1b9.5x6.6x0.9x
Price to Earnings Ratio

6.6x


Total Market Cap: R$4.0tTotal Earnings: R$608.1bTotal Revenue: R$4.6tTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Market Price to Earnings3Y Average 9.7x202420252026
Current Market PE
  • Investors are optimistic on the Brazilian market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 13.9x which is higher than its 3-year average PE of 9.7x.
Past Earnings Growth
  • The earnings for companies in the Brazilian industry have declined 13% per year over the last three years.
  • Revenues have also declined 4.8% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Sector Trends

Which sectors have driven the changes within the Brazilian Market?

BR Market0.31%
Healthcare4.13%
Real Estate2.66%
Tech2.59%
Consumer Discretionary2.26%
Energy2.23%
Utilities1.86%
Financials1.01%
Consumer Staples-1.00%
Industrials-1.72%
Telecom-2.36%
Materials-4.29%
Sector PE
  • Investors favour the Healthcare sector the most for future growth, which is trading above its 3-year average PE ratio of 50.6x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 26.7%, which is higher than its past year's earnings growth of 7.1% per year.
  • The Energy sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 5.9x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare sector, expecting annual earnings growth of 27% over the next 5 years.
  • This is better than its past earnings growth rate of 7.1% per year.
  • In contrast, the Energy industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
BPAC11 Banco BTG PactualR$61.855.7%
+R$16.1b		85.7%PE18.7xFinancials
AZUL53 AzulR$0.00016-27.6%
R$6.8b		n/aPS0.4xIndustrials
RDOR3 Rede D'Or São LuizR$44.645.3%
+R$4.9b		48.4%PE22.2xHealthcare
ENEV3 EnevaR$21.9010.4%
+R$3.9b		78.6%PE1232.6xUtilities
BBAS3 Banco do BrasilR$26.461.7%
+R$2.5b		-5.5%PB0.8xFinancials
See more

Market Insights

Header cover image
Alternatives part 2: 2026 and beyond 🔭
Richard Bowman avatar
Richard Bowman
|
|
Deep dive into the exciting world of Private Equity, Real Estate, Private Credit, Infrastructure & Transport and Hedge Funds.
Continue reading
Dotcom Bubble vs. Now 🫧
Last Week

Dotcom Bubble vs. Now 🫧

Latest News

VALE3
R$84.09
Vale
7D
-5.8%
1Y
45.6%

There May Be Reason For Hope In Vale's (BVMF:VALE3) Disappointing Earnings

Feb 19
There May Be Reason For Hope In Vale's (BVMF:VALE3) Disappointing Earnings
ABEV3
R$16.17
Ambev
7D
-2.1%
1Y
46.5%

ABEV3: Profitability Execution Risk May Limit Appeal Despite Cash Flow Outlook

Analysts have nudged their Ambev price target higher, with the fair value estimate moving from R$13.98 to R$14.81, citing expectations for profitability-led earnings and cash flow growth into 2026. Analyst Commentary Recent research has focused on how Ambev might balance earnings quality with cash generation as it approaches 2026.
WEGE3
R$51.37
WEG
7D
-4.9%
1Y
-1.4%

WEGE3: Tariff And Renewables Risks Will Pressure Overvalued Shares

Analysts have raised their price target on WEG to R$55, citing what they view as overly cautious market sentiment on tariffs and renewables orders, along with Street models for 2026-27 EBITDA that they estimate are roughly 7% below their own projections. Analyst Commentary Even with the new R$55 price target, there is still a split in how analysts see the risk and reward for WEG.
SUZB3
R$57.13
Suzano
7D
-1.9%
1Y
-0.9%

We Think That There Are Issues Underlying Suzano's (BVMF:SUZB3) Earnings

Feb 17
We Think That There Are Issues Underlying Suzano's (BVMF:SUZB3) Earnings
BBAS3
R$26.46
Banco do Brasil
7D
1.7%
1Y
-5.5%
BBSE3
R$33.58
BB Seguridade Participações
7D
-11.1%
1Y
-15.8%

BBSE3: Higher Margin Outlook Will Support Undervalued Shares Despite Recent Downgrade

Analysts have adjusted their price target on BB Seguridade Participações slightly higher to about R$38.00, reflecting updated assumptions on discount rate, revenue growth, profit margins and future P/E after recent research, including a downgrade from Goldman Sachs. Analyst Commentary Recent research around BB Seguridade Participações is mixed, with the updated R$38.00 price target sitting alongside a fresh downgrade from Goldman Sachs.
VIVT3
R$40.89
Telefônica Brasil
7D
-1.5%
1Y
56.5%
TIMS3
R$27.02
TIM
7D
-4.5%
1Y
58.1%

TIM S.A. (BVMF:TIMS3) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Feb 13
TIM S.A. (BVMF:TIMS3) Full-Year Results: Here's What Analysts Are Forecasting For This Year
BPAC11
R$61.85
Banco BTG Pactual
7D
5.7%
1Y
85.7%
RDOR3
R$44.64
Rede D'Or São Luiz
7D
5.3%
1Y
48.4%

RDOR3: Refined Discount Rate And Profitability Assumptions Will Support Future Repricing

Analysts have slightly raised their fair value estimate for Rede D'Or São Luiz to R$50.59 from R$49.71. They cite modest adjustments in the discount rate, revenue growth, profit margin and future P/E assumptions.
ENEV3
R$21.90
Eneva
7D
10.4%
1Y
78.6%

ENEV3: Softer Assumptions And Governance Agenda Will Support A Steady Outlook

Analysts have lifted their fair value estimate for Eneva from R$22.61 to R$23.90, pointing to slightly lower assumed discount rates and modestly better projected profit margins as the main drivers of the updated price target. What's in the News Eneva has scheduled a Special and Extraordinary Shareholders Meeting for February 5, 2026, giving investors a clear date to watch for potential corporate decisions that could affect the capital structure or governance (Key Developments).
B3SA3
R$17.75
B3 - Brasil Bolsa Balcão
7D
2.2%
1Y
57.2%

B3SA3: Buyback Review And Equity Swaps Will Support Fairly Balanced Outlook

Analysts have nudged their price target for B3 up from R$15.91 to R$16.38, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels. What's in the News Board meeting on January 29, 2026, to re elect Maria Luiza Lage de Mattos Levi as an external member and financial expert on the Audit Committee, with the committee composition ratified to include Cristina Anne Betts as coordinator and independent, non bound director (Key Developments).
CXSE3
R$17.80
Caixa Seguridade Participações
7D
-2.6%
1Y
15.4%

CXSE3: Future Returns Will Depend On Margins And P E Multiple Stability

Analysts have nudged their price target for Caixa Seguridade Participações slightly higher to R$18.50, reflecting updated assumptions around discount rates, profit margins and forward P/E, while leaving revenue growth expectations broadly unchanged. Valuation Changes Fair Value: The analyst fair value estimate has moved slightly higher from R$18.43 to R$18.50 per share.
PRIO3
R$54.93
Prio
7D
5.2%
1Y
42.6%

PRIO3: Refined Insurance Models And Index Inclusion Will Support Upside Potential

Narrative Update Analysts have maintained Prio's fair value estimate at $62.00 and refined assumptions on discount rate, revenue growth, profit margin, and future P/E to reflect updated sector models and recent insurance earnings commentary. Analyst Commentary Recent Street research on Prio highlights how updated insurance sector models are feeding into valuation work, with analysts fine tuning price targets rather than making wholesale changes.
AZUL53
R$0.00016
Azul
7D
-27.6%
1Y
n/a
ANCR11
R$447.99
Fundo de Investimento Imobiliário - FII Ancar IC
7D
40.0%
1Y
517.9%